Lisata Therapeutics, Inc. Share Price

Lisata Therapeutics, Inc. Share Price

NASDAQ: LSTA | Micro Cap
$1.00
-$0.07 (-7%) Last updated on 30 Oct, 2026 | 01:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Lisata Therapeutics, Inc. Stock Performance

Open
$1.05
Prev. Close
$1.07
Circuit Range
N/A
Day Range
$1.00 - $1.05
Year Range
$0.99 - $5.07
Volume
512
Average Traded
$1.03

Lisata Therapeutics, Inc. Share Price Today

As of 30 October 2026, Lisata Therapeutics, Inc.'s share price is $1.00. The stock opened at $1.05, compared to its previous close of $1.07. During today's trading session, Lisata Therapeutics, Inc.'s share price traded between $1.00 and $1.05, with an average price of $1.02. Over the past 52 weeks, the stock has recorded a high of $5.07 and a low of $0.99. In terms of performance, Lisata Therapeutics, Inc.'s share price has declined by 68.90% over the last six months and is down 64.21% on a year-on-year basis.

Lisata Therapeutics, Inc. Share Price Chart

Line chart of the Lisata Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 0.99 to 1.05, ending at 0.99.
$1.00$1.05
L
Show Current Price
H

Lisata Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$8.64M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.35
Revenue (TTM)
$170.00M
Return On Equity (TTM)
-177.35%
Profit Margin
-9758.82%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
31.06%

Lisata Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.10$0.00$0.00
Net Profit-$4.25-$2.95-$4.49-$2.93
Net Profit MarginN/A-2950.00%N/AN/A
Income ChangeN/A30.59%-52.20%34.74%

Lisata Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$1.00$0.17
Net Profit-$54.23-$20.84-$19.99-$16.59
Net Profit MarginN/AN/A-1999.00%-9758.82%
Income ChangeN/A61.57%4.08%17.01%

About Lisata Therapeutics, Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Lisata Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.54
$0.99
-31.14%
Sep 2026
$1.51
$1.45
-22.73%
Aug 2026
$1.05
$1.87
+78.10%
Jul 2026
$3.40
$1.05
-69.21%
Jun 2026
$3.60
$3.41
+7.23%
May 2026
$3.26
$3.18
-0.63%
Apr 2026
$5.01
$3.20
-36.25%
Mar 2026
$4.27
$5.02
+20.38%
Feb 2026
$4.60
$4.17
-8.65%
Jan 2026
$1.93
$4.57
+145.43%
Dec 2025
$1.95
$1.86
-9.49%
Nov 2025
$2.66
$2.06
-26.08%

LSTA Share Price FAQs